Share, email, print, bookmark SOURCE reports.

[broadstreet zone=”54526″]

WASHINGTON DC – Pfizer announced today, February 11, that parents will have to wait a little longer for a COVID vaccine for children under age 5.

Pfizer-BioNTech said it is postponing its application to the U.S. Food and Drug Administration to expand the use of its two-dose Covid-19 vaccine for children ages 6 months to 4 years.

The company said it still needs more data on the effects of a three-dose vaccine after two doses didn’t create a strong enough immune response.

[broadstreet zone=”58610″]

For infants, toddlers, & preschoolers, Pfizer’s vaccine has a dosage of 3 micrograms.

For children ages 5 to 11, the dosage is higher, at 10 micrograms.

Pfizer asked the FDA this month to authorize these first two doses, with a plan to submit additional data in the coming weeks on a third dose. The full vaccination series would be three doses.

More conclusive research is expected by early April, said Pfizer.

By editor

Susan Petroni is the former editor for SOURCE. She is the founder of the former news site, which as of May 1, 2023, is now a self-publishing community bulletin board. The website no longer has a journalist but a webmaster.